By John Halamka and Paul Cerrato — A closer look at the latest FDA list of approved AI-enabled devices suggests these digital tools are poised to have a significant impact on patient care.

Mayo Clinic and Mercy are making a significant advancement in their global, first-of-its-kind 10-year collaboration agreement signed in the summer of 2022. As founding members of Mayo Clinic Platform_Connect, the two organizations will now be working together to analyze de-identified patient data as they search for new ways to diagnose, treat and prevent disease, providing better outcomes and lower costs of care.

By John Halamka and Paul Cerrato — Several innovators have created algorithms to predict and manage this life-threatening complication.

By John Halamka and Paul Cerrato — Regulators who put too many restrictions on the technology can slow down innovation, but if they set up guardrails that aren’t strict enough, they needlessly endanger patients’ lives.

The first-of-its-kind alliance moves into new regions to transform global healthcare and improve access, diagnostics and treatments for patients everywhere.

Mayo Clinic Platform_Accelerate celebrated the graduation of its fourth cohort of health tech startups, including nine innovative businesses from around the world. During the graduation event, held March 28 in Eagan, Minnesota, each company presented progress and outcomes from the 20-week accelerator program, providing a glimpse into the future of medicine.

By John Halamka and Paul Cerrato — The latest research suggests that these digital tools will eventually become useful medical assistants, but we still need to watch for unpredictable fabrications and misstatements.